Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
Authors:
- Jing-Jing LuJLJing-Jing Lu
- Yi-Ping DuYDYi-Ping Du
- Chun-Xia FengCFChun-Xia Feng
- Li-Qiang WangLWLi-Qiang Wang
- Min-Bin ChenMCMin-Bin Chen
Open Access
- 1 March 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 97 (12) , e0144
Abstract
The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been presented to be a prognostic indicator in several types of cancer. However, these issues have not been concluded yet. The present study was therefore performed to determine the prognostic value of NLR and PLR in gastric cancer (GC). A total of 182 GC patients, diagnosed between January 2011 and January 2014, were enrolled in the study. The clinicopathological parameters, laboratory analyses, and outcomes were collected. The association between NLR, PLR, and clinicopathological characters was analyzed with univariate and multivariate analyses. NLR was significantly related to age (P = .026), surgery (P = .006), node status (P = .004), and clinical stage (P = .009). The median overall survival (OS) and progression-free survival (PFS) were poor in the High-NLR group (OS: 36.0 vs 20.5 months, P < .001, PFS: 33.0 vs 12.0 months, P < .001) and High-PLR group (OS: 31.5 vs 18.5 months, P = .003, PFS: 26.0 vs 11.0 months, P = .01). Multivariate analyses indicated both surgery [for OS hazard ratio (HR) = 2.092, 95% confidence interval (95% CI): 1.345–3.253, P = .001; for PFS HR = 1.939, 95% CI: 1.259–2.988, P = .003] and NLR (for OS HR = 1.585, 95% CI: 1.011–2.485, P = .045) were independent prognostic factors. Elevated NLR and PLR were related with poor prognosis in GC patients before treatment. The NLR was an independent prognostic factor for OS. More studies should be conducted to address the potential prognostic value of NLR and PLR in GC.Keywords
This publication has 33 references indexed in Scilit:
- The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?Annals of Surgical Oncology, 2015
- Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelJournal of Translational Medicine, 2015
- The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMedical Oncology, 2014
- Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung CancerPLOS ONE, 2014
- The role of preoperative neutrophil–lymphocyte and platelet–lymphocyte ratio in patients after radical resection for gastric cancerBiomarkers, 2014
- Inflammation lights the way to metastasisNature, 2014
- Prognostic Significance of Neutrophil Lymphocyte Ratio in Patients with Gastric Cancer: A Meta-AnalysisPLOS ONE, 2014
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer, 2013
- Gastric Cancer—An Enigmatic and Heterogeneous DiseaseJAMA, 2010
- The Immunobiology of Cancer Immunosurveillance and ImmunoeditingImmunity, 2004